Past abuses at the CIA-funded Addiction Research Center (ARC) are a stark reminder of systemic medical racism in the U.S. This historical mistreatment of Black Americans has led to a pervasive lack of trust in medical institutions, particularly concerning innovations like psychedelic medicine. Despite the potential benefits of psychedelics for mental health, Black individuals remain significantly underrepresented in clinical trials. Factors such as financial barriers, exclusionary practices, and mistrust hinder participation. Addressing these issues is vital for ensuring equitable access to scientific advances that could benefit Black communities.
The past research abuses at the Addiction Research Center (ARC) are emblematic of a broader, systemic issue of medical racism in U.S. healthcare.
To heal and advocate for Black communities, it's essential to acknowledge the painful legacy of the CIA-funded ARC and strive for equitable representation in psychedelic research.
Collection
[
|
...
]